Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 45/100

Failure Rate

0.0%

0 terminated/withdrawn out of 4 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 3 completed trials have results

Key Signals

1 recruiting

Enrollment Performance

Analytics

N/A
4(100.0%)
4Total
N/A(4)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (4)

Showing 4 of 4 trials
NCT05728918Not ApplicableCompleted

Effectiveness of Antrodia Cinnamomea Mycelia on Improving Immune Response in Subhealth People

Role: lead

NCT05542160Not ApplicableCompleted

Effectiveness of IRK-19® on Body Weight Control

Role: lead

NCT05738655Not ApplicableRecruiting

Effectiveness of Pumpkin Seed Extract on Improving Blood Sugar Level in Subhealth Subjects

Role: lead

NCT05309161Not ApplicableCompleted

Efficacy Testing of Crassocephalum Rabens Extract Capsules

Role: lead

All 4 trials loaded